BELINDA COWART: Open Payments
NPI 1619317120 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,034 in 180 payments from 25 companies in 2025. Trend: 2023 $2,538 · 2024 $4,092 · 2025 $4,034
Food & beverage: $3,904Education: $130
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 12 | $432 |
| AstraZeneca Pharmaceuticals LP | 19 | $409 |
| GlaxoSmithKline, LLC. | 21 | $319 |
| United Therapeutics Corporation | 14 | $317 |
| Regeneron Healthcare Solutions, Inc. | 11 | $315 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 12 | $309 |
| Insmed, Inc. | 10 | $230 |
| Grifols USA, LLC | 10 | $226 |
| Verona Pharma, Inc. | 12 | $198 |
| Viatris Specialty LLC | 7 | $167 |
Products named: DUPIXENT, Tyvaso, TRELEGY ELLIPTA, Prolastin-C Liquid, Arikayce, Ohtuvayre, YUPELRI, Hillrom - Vest System Model 105 Home Care.
Industry payments across LA — which companies pay providers there.
